Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $31.7800 (-1.97%) ($31.4400 - $33.0600) on Wed. Apr. 25, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 48 | Latest Price | $31.7800(-1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.035% in a week (0% probabilities). VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $33.63 | 5 Day Moving Average | $33.38(-4.79%) | 10 Day Moving Average | $34.2(-7.08%) | 20 Day Moving Average | $33.63(-5.5%) | To recent high | -27.9% | To recent low | 0% | Market Cap | $1.974b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |